127127353
-
News
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer…
Read More »
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer…
Read More »